We got an invitation too.
Unconfigured Ad
Collapse
X
-
-
There's a fair bit of information on the Nanopore website now:
Here's my rough summary:
- Restricted open-access philosophy for results and software development via login at nanoporeonline.com
- 6 week MAP cycles, 2 weeks for configuration, 4 for your own experiments. Burn-in cell in week 1, two experimental flow cells delivered week 3, two more week 5
- Can duck out at any time with a deposit refund
- Can continue on in the program for the next cycle, or stop and give someone else a go
- Cost is $1,000 deposit (covers all MAP cycles) + $250 delivery (per cycle for multiple deliveries & returns) + taxes where relevant
- ONP receives diagnostic statistics via the Grouper instrument software, but results are yours to keep
- ONP requests that people remain tight-lipped until the end of the burn-in period, so people will be quiet about this for at least the next couple of weeks
- Computer requirements are not mentioned on this page, although it is stated that Macs are not yet fully supported
Comment
-
Unfortunately my email was:
Thank you very much for taking the time to apply to join the MinION Access programme (MAP). We received a large number of applications from a broad range of applicants and unfortunately cannot invite every applicant at this time. Unfortunately we cannot offer you a place in the first wave of MAP however we intend to make more places available in the future and hope that you are happy to remain on our list of interested participants.
Once again we thank you for your interest. If you would prefer not to be considered for MAP in the future please email us on [email protected].
I hope those of us that did get in keep everyone posted in this thread.
Comment
-
I just noticed Oxford Nanopore thinks solid state nanopore is the future. They added Harvard's solid state nanopore team in 2011. If this new team develops fast enough, the current gen of protein nanopore might just be a stopgap product?
Comment
Latest Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 10:13 AM
|
0 responses
13 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:13 AM
|
||
|
Started by SEQadmin2, 07-31-2026, 02:55 AM
|
0 responses
26 views
0 reactions
|
Last Post
by SEQadmin2
07-31-2026, 02:55 AM
|
||
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
Comment